Two cases of clear cell sarcoma with different clinical and genetic features: Cutaneous type with BRAF mutation and subcutaneous type with KIT mutation

British Journal of Dermatology

Volumn 169, Issue 6, 2013, Pages 1346-1352

  Park, B M ^a   Jin, S A ^a   Choi, Y D ^a   Shin, S H ^a   Jung, S T ^a   Lee, J B ^a   Lee, S C ^a   Yun, S J ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 1; B RAF KINASE; CHIMERIC PROTEIN; DACARBAZINE; EWSR1 ATF1 FUSION PROTEIN; GENOMIC DNA; HYBRID PROTEIN; INTERFERON; KIT PROTEIN; MONOCLONAL ANTIBODY HMB 45; PROTEIN S 100; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; BRAF PROTEIN, HUMAN; STEM CELL FACTOR RECEPTOR;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CASE REPORT; CLEAR CELL SARCOMA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EWING SARCOMA; EWSR1 GENE; EXON; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; GENE REARRANGEMENT; GENETIC ANALYSIS; GIANT CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INGUINAL LYMPH NODE; LYMPHADENOPATHY; MITOSIS RATE; ONCOGENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY; SUBCUTANEOUS FAT; TUMOR BIOPSY; TUMOR CELL; WIDE EXCISION; FATALITY; GENETICS; INGUINAL CANAL; LYMPH NODE METASTASIS; MUTATION; SKIN TUMOR; YOUNG ADULT;

ADULT; FATAL OUTCOME; FEMALE; HUMANS; INGUINAL CANAL; LYMPHATIC METASTASIS; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-KIT; SARCOMA, CLEAR CELL; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84889073458     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12480     Document Type: Article

References (28)

1. Enzinger FM,. Clear-cell sarcoma of tendons and aponeuroses. An analysis of 21 cases. Cancer 1965; 18: 1163-74.
2. Chung EB, Enzinger FM,. Malignant melanoma of soft parts. A reassessment of clear cell sarcoma. Am J Surg Pathol 1983; 7: 405-13.
3. Hisaoka M, Ishida T, Kuo TT, et al,. Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases. Am J Surg Pathol 2008; 32: 452-60.
4. Kawai A, Hosono A, Nakayama R, et al,. Clear cell sarcoma of tendons and aponeuroses: a study of 75 patients. Cancer 2007; 109: 109-16.
5. Hantschke M, Mentzel T, Rütten A, et al,. Cutaneous clear cell sarcoma: a clinicopathologic, immunohistochemical, and molecular analysis of 12 cases emphasizing its distinction from dermal melanoma. Am J Surg Pathol 2010; 34: 216-22.
6. Falconieri G, Bacchi CE, Luzar B,. Cutaneous clear cell sarcoma: report of three cases of a potentially underestimated mimicker of spindle cell melanoma. Am J Dermatopathol 2012; 34: 619-25.
7. Rodríguez-Martín M, Sáez-Rodríguez M, Esquivel B, et al,. Clear cell sarcoma: a case mimicking primary cutaneous malignant melanoma. Indian J Dermatol 2009; 54: 168-72.
8. Kindblom LG, Lodding P, Angervall L,. Clear-cell sarcoma of tendons and aponeuroses. An immunohistochemical and electron microscopic analysis indicating neural crest origin. Virchows Arch A Pathol Anat Histopathol 1983; 401: 109-28.
9. Dim DC, Cooley LD, Miranda RN,. Clear cell sarcoma of tendons and aponeuroses: a review. Arch Pathol Lab Med 2007; 131: 152-6.
10. Graadt van Roggen JF, Mooi WJ, Hogendoorn PC,. Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) and cutaneous melanoma: exploring the histogenetic relationship between these two clinicopathological entities. J Pathol 1998; 186: 3-7.
11. Zucman J, Delattre O, Desmaze C, et al,. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 1993; 4: 341-5.
12. Thway K, Fisher C,. Tumors with EWSR1-CREB1 and EWSR1-ATF1 fusions: the current status. Am J Surg Pathol 2012; 36: e1-11.
13. Mrõzek K, Karakousis CP, Perez-Mesa C, Bloomfield CD,. Translocation t(12;22)(q13;q12.2-12.3) in a clear cell sarcoma of tendons and aponeuroses. Genes Chromosom Cancer 1993; 6: 249-52.
14. Panagopoulos I, Mertens F, Dêbiec-Rychter M, et al,. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses. Int J Cancer 2002; 99: 560-7.
15. Garcia JJ, Kramer MJ, Mackey ZB, et al,. Utility of CD117 immunoreactivity in differentiating metastatic melanoma from clear cell sarcoma. Arch Pathol Lab Med 2006; 130: 343-8.
16. Langezaal SM, Graadt van Roggen JF, Cleton-Jansen AM, et al,. Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts). Br J Cancer 2001; 84: 535-8.
17. Yang L, Chen Y, Cui T, et al,. Identification of biomarkers to distinguish clear cell sarcoma from malignant melanoma. Hum Pathol 2012; 43: 1463-70.
18. Panagopoulos I, Mertens F, Isaksson M, Mandahl N,. Absence of mutations of the BRAF gene in malignant melanoma of soft parts (clear cell sarcoma of tendons and aponeuroses). Cancer Genet Cytogenet 2005; 156: 74-6.
19. Davis IJ, Kim JJ, Ozsolak F, et al,. Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers. Cancer Cell 2006; 9: 473-84.
20. Rodriguez E, Sreekantaiah C, Reuter VE, et al,. t(12;22)(q13;q13) and trisomy 8 are nonrandom aberrations in clear-cell sarcoma. Cancer Genet Cytogenet 1992; 64: 107-10.
21. Antonescu CR, Nafa K, Segal NH, et al,. EWS-CREB1: a recurrent variant fusion in clear cell sarcoma-association with gastrointestinal location and absence of melanocytic differentiation. Clin Cancer Res 2006; 12: 5356-62.
22. Segal NH, Pavlidis P, Noble WS, et al,. Classification of clear-cell sarcoma as a subtype of melanoma by genomic profiling. J Clin Oncol 2003; 21: 1775-81.
23. Curtin JA, Busam K, Pinkel D, Bastian BC,. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006; 24: 4340-6.
24. Hornick JL, Fletcher CD,. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol 2002; 117: 188-93.
25. Gambichler T, Pantelaki I, Othlinghaus N, et al,. Deep intronic point mutations of the KIT gene in a female patient with cutaneous clear cell sarcoma and her family. Cancer Genet 2012; 205: 182-5.
26. Negri T, Brich S, Conca E, et al,. Receptor tyrosine kinase pathway analysis sheds light on similarities between clear-cell sarcoma and metastatic melanoma. Genes Chromosom Cancer 2012; 51: 111-26.
27. Hocar O, Le Cesne A, Berissi S, et al,. Clear cell sarcoma (malignant melanoma) of soft parts: a clinicopathologic study of 52 cases. Dermatol Res Pract 2012; 2012: 984096.
28. Sharma A, Trivedi NR, Zimmerman MA, et al,. Mutant V599E B-Raf regulates growth and vascular development of malignant melanoma tumors. Cancer Res 2005; 65: 2412-21.